Global Brain Tumor Diagnostics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Diagnostic Type;

Lumbar Puncture, Biopsy, Molecular Testing, and Others.

By Tumor Type;

Metastatic, Meningioma, Glioblastoma, Astrocytoma, and Others.

By End User;

Hospitals, Diagnostics Centers, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn438535983 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Brain Tumor Diagnostics Market (USD Million), 2021 - 2031

In the year 2024, the Global Brain Tumor Diagnostics Market was valued at USD 907.36 million. The size of this market is expected to increase to USD 1,328.70 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.6%.

The global brain tumor diagnostics market is a critical segment within the broader healthcare industry, dedicated to the detection and characterization of brain tumors through advanced imaging technologies and diagnostic procedures. Brain tumors represent a complex and diverse group of neoplasms that can arise from various cells within the brain or its surrounding tissues. Accurate and timely diagnosis is paramount for determining appropriate treatment strategies and optimizing patient outcomes.

Key diagnostic modalities driving the market include magnetic resonance imaging (MRI), computed tomography (CT) scans, positron emission tomography (PET) scans, and other advanced neuroimaging techniques. MRI, in particular, plays a central role due to its ability to provide detailed images of brain structures with high resolution and contrast. These imaging technologies enable healthcare providers to visualize the location, size, and characteristics of brain tumors, aiding in the formulation of precise treatment plans tailored to individual patient needs.

The integration of molecular diagnostics and biomarker analysis has further enhanced the diagnostic capabilities in the brain tumor diagnostics market. Molecular testing allows for the identification of specific genetic mutations and biomarkers associated with different types of brain tumors, facilitating more accurate diagnosis and prognostic assessment. This personalized approach not only improves the accuracy of diagnosis but also supports the development of targeted therapies and personalized treatment strategies, marking a significant advancement in the field of neuro-oncology. As technological innovations continue to evolve and healthcare systems worldwide prioritize early detection and intervention, the global brain tumor diagnostics market is poised for continued growth and innovation in the years ahead.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Diagnostic Type
    2. Market Snapshot, By Tumor Type
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Brain Tumor Diagnostics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Advanced Imaging
        2. Molecular Diagnostics
        3. Biomarker Analysis
      2. Restraints
        1. Cost constraints
        2. Limited accessibility
        3. Technological barriers
      3. Opportunities
        1. Advanced Imaging
        2. Biomarker Discovery
        3. Genomic Profiling
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Brain Tumor Diagnostics Market, By Diagnostic Type, 2021 - 2031 (USD Million)
      1. Lumbar Puncture
      2. Biopsy
      3. Molecular Testing
      4. Others
    2. Global Brain Tumor Diagnostics Market, By Tumor Type, 2021 - 2031 (USD Million)
      1. Metastatic
      2. Meningioma
      3. Glioblastoma
      4. Astrocytoma
      5. Others
    3. Global Brain Tumor Diagnostics Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Diagnostics Centers
      3. Others
    4. Global Brain Tumor Diagnostics Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia/New Zealand
        5. South Korea
        6. ASEAN
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. GE Healthcare
      2. Koninklijke Philips N.V.
      3. Siemens Healthineers
      4. Fujifilm Corporation
      5. Hitachi, Ltd.
      6. Hologic, Inc.
      7. NantOmics
      8. Thermo Fisher Scientific
  7. Analyst Views
  8. Future Outlook of the Market